4.7 Review

Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges

Journal

NANOMEDICINE
Volume 10, Issue 15, Pages 2405-2422

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/NNM.15.68

Keywords

anticancer; biodistribution; cellular interaction; graphene; graphene oxide; inorganic nanoparticle; in vitro in vivo toxicity; nanotoxicity; theranostics

Ask authors/readers for more resources

As an inorganic nanomaterial, graphene nanocomposites have gained much attention in cancer nanotechnology compared with the other inorganic nanomaterial in recent times. Although a relatively new drug carrier, it has been extensively explored as a potential chemotherapeutic carrier and theranostic because of its numerous physicochemical properties, including, capability of multiple pay load, functionalization for drug targeting and photothermal effect. Despite potential benefit, its translation from bench to bed-side in cancer therapy is challenged due to its toxicity concern. Here, we discussed the present progress and future possibilities of graphene nanocomposites as a cancer theranostic. Moreover, the paper also exemplifies the effects of graphene/graphene oxide on tissues and organ functions in order to understand the extent and mechanism of toxicity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available